[ad_1] NEW YORK, Nov. 17, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting […]
Tag: THE ROSEN LAW FIRM
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
[ad_1] NEW YORK, Nov. 16, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. […]
KBR Investors Have Opportunity to Lead KBR, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
[ad_1] NEW YORK, Nov. 16, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both […]
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Nov. 15, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July […]
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, Nov. 15, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September […]
